ليست عنوان مقالات لاتين Can we influence health status and semen quality of breeding stallions by feeding a prebiotic feed additive during one breeding season? Cancer risks in children with congenital malformations in the nervous and circulatory system—A population based cohort study

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Can we influence health status and semen quality of breeding stallions by feeding a prebiotic feed additive during one breeding season?

2

Can we integrate bioinformatics data on the Internet?

3

Can we interpret the evolution of coastal land use conflicts? Using Artificial Neural Networks to model the effects of alternative development policies

4

Can we justify historical control groups when using animal models?

5

Can We Learn From History and Unite as Emergency Physicians?

6

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 1: Defining the Agenda

7

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 1: Defining the Agenda

8

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 2: Controlling the Agenda

9

Can We Learn from the Past? A History of the Kennedy Center Alliance for Arts Education Part 2: Controlling the Agenda

10

Can we learn more from the data underlying the statistical α–β model with respect to the dynamical behavior of avalanches?

11

Can We Leave Cognition to Cognitive Psychologists? Comments on an Article by George Loewenstein

12

Can we live on the brane in Schwarzschild–anti de Sitter black hole?

13

Can we maintain turf to customers’ satisfaction with less water?

14

CAN WE MANAGE ALLIGATOR WEED BETTER IN AUSTRALIA? LESSONS FROM HERBICIDE TRIALS

15

Can we manage ecosystems in a sustainable way?

16

Can we map swelling clays with remote sensing?

17

Can we measure in semi-inclusive eN or NN scattering?

18

Can we measure ecological sustainability? Landscape pattern as an indicator for naturalness and land use intensity at regional, national and European level

19

Can We Measure How Hot the Plaque Is? Not Yet, But…

20

Can we meet targets for biofuels and renewable energy in transport given the constraints imposed by policy in agriculture and energy?

21

Can We Minimize the Effects of Opioids on the Bowel and Still Achieve Adequate Pain Control?

22

Can we model organismic causes of working memory, efficiency and fluid intelligence? A meta-subjective perspective

23

Can We Modify Late Functional Outcome in Ebstein Anomaly by Altering Surgical Strategy?

24

Can we observe galaxies that recede faster than light ? —A more clear-cut answer

25

Can we observe the quark gluon plasma in cosmic ray showers

26

Can we optimise treatment of thrombosis?

27

Can we overcome automobile dependence? : Physical planning in an age of urban cynicism

28

Can we play Fun Gay? Disjuncture and difference, and the precarious mobilities of millennial queer youth narratives

29

Can we predict biological condition of stream ecosystems? A multi-stressors approach linking three biological indices to physico-chemistry, hydromorphology and land use

30

Can we predict crashes? The case of the Brazilian stock market

31

Can we Predict Fate of Bleeding in Early Pregnancy?

32

Can we predict habitat quality from space? A multi-indicator assessment based on an automated knowledge-driven system

33

Can we predict long-term sequelae after fractures of the clavicle based on initial findings? A prospective study with nine to ten years of follow-up

34

Can We Predict Long-Term Survival After Pulmonary Metastasectomy for Renal Cell Carcinoma?

35

Can We Predict Patients’ Cooperation During Phacoemulsification Surgery Under Topical Anesthesia?

36

Can we predict performance and spatial structure of two-species mixtures using only single species information from monocultures?

37

Can we predict performance and spatial structure of two-species mixtures using only single species information from monocultures?

38

Can we predict successful completion of the common foundation programme at interview?

39

Can we predict temperature-dependent chemical toxicity to marine organisms and set appropriate water quality guidelines for protecting marine ecosystems under different thermal scenarios?

40

Can we predict the duration of respiratory support in transient tachypnea of the newborn?

41

Can we predict the failure point of a loaded composite material? Original Research Article

42

Can we predict the fate of the Universe?

43

Can we predict the future food production? A sensitivity analysis

44

Can We Predict Thromboembolic Events in Low-Risk Patients Undergoing Catheter Ablation of Atrial Fibrillation?: The Hanging CHAD

45

Can we predict uranium bioavailability based on soil parameters? Part 1: Effect of soil parameters on soil solution uranium concentration

46

Can we predict uranium bioavailability based on soil parameters? Part 2: Soil solution uranium concentration is not a good bioavailability index

47

Can we predict which head and neck cancer survivors develop fears of recurrence?

48

Can we predict which patients with implantable cardioverter defibrillators receive appropriate shock therapy? A study of 155 patients

49

Can We Prepare IVF Culture Media Two Days Before Ovum Pick up Without Affecting Embryological Parameters? A Retrospective Case-Matched Study

50

Can we prepare our bodies over the year to cope with Ramadan fasting more easily? Imam Reza’s health and dietary recommendations for different months of the year

51

Can we prevent azole resistance in fungi?

52

Can We Prevent Breast Cancer?

53

Can We Prevent Heart Failure With Exercise?

54

Can we profile sex offenders? A review of sex offender typologies

55

Can We Provide Reperfusion Therapy to All Unselected Patients Admitted With Acute Myocardial Infarction?

56

Can we pull the plug on warfarin in atrial fibrillation?

57

Can we put aside the LNT dilemma by the introduction of the controllable dose?

58

Can we quantify the benefits of DMDs in multiple sclerosis?

59

Can we rationally design molecularly imprinted polymers?

60

Can we rationally design molecularly imprinted polymers? Original Research Article

61

Can we reach consensus between marine ecological models and DEB theory? A look at primary producers

62

Can we really grow new blood vessels?

63

Can we really learn from model pathogens?

64

Can we really measure the internal energy of hot nuclei with a 4π detection array? Original Research Article

65

Can we really measure the relative permeabilities using the micropore membrane method?

66

Can we really predict risk of cancer?

67

Can we reconcile consumer wishes and provider restraints?

68

Can we reconstruct browsing history and how far back? Lessons from Vaccinium parvifolium Smith in Rees

69

Can we recover information from concordant pairs in binary matched pairs?

70

Can We Reduce Salinity Effects by the Application of Humic Acid on Native Turfgrasses in order to Attain Sustainable Landscape?

71

Can We Reduce Secondary Surgical Interventions and Length of Hospitalization in Percutaneous Nephrolithotomy?

72

Can We Reduce Secondary Surgical Interventions and Length of Hospitalization in Percutaneous Nephrolithotomy?

73

Can we reduce the burden of musculoskeletal conditions? The European action towards better musculoskeletal health

74

Can we reduce the caesarean section rate?

75

Can We Re-Imagine Research So It Is Timely, Relevant and Responsive? Comment on “Experience of Health Leadership in Partnering with University-Based Researchers in Canada: A Call to ‘Re-Imagine’ Research”

76

Can we relate MeCP2 deficiency to the structural and chemical abnormalities in the Rett brain?

77

Can we reliably predict long-term mortality after exercise testing? An external validation

78

Can We Rely on Frozen Sections of a Rectal Biopsy for One-stage Trans-anal Pull-through Operation in Hirschsprung's Disease?

79

Can we rely on the multiplex ligation-dependent probe amplification method (MLPA) for prenatal diagnosis?

80

Can we Replace Arterial Blood Gas Analysis by Pulse Oximetry in Neonates with Respiratory Distress Syndrome, who are Treated According to INSURE Protocol?

81

Can we replace the 90-minute thrombolysis in myocardial infarction (TIMI) flow grades with those at 60 minutes as a primary end point in thrombolytic trials?

82

Can we reposition the preferred geological conditions necessary for an infiltration gallery? The development of a synthetic infiltration gallery Original Research Article

83

Can We Resolve Contradictions between Process Dissociation Models?

84

Can we RESOLVE the treatment of sepsis?

85

Can we restore the Colorado River delta?

86

Can we reverse the HIV/AIDS pandemic with an expanded response?

87

Can we screen for pelvic organ prolapse without a physical examination in epidemiologic studies?

88

Can we simulate regional groundwater flow in a karst system using equivalent porous media models? Case study, Barton Springs Edwards aquifer, USA

89

Can we skill and activate children through primary school physical education lessons? “move it groove it”—a collaborative health promotion intervention

90

Can We Slow Down the Global Increase of Adiposity?

91

Can we solve the mysteries of the National Vietnam Veterans Readjustment Study?

92

Can we stand the heat?

93

Can we start to think about consensus-oriented clinical practices?

94

Can we still beat “buy-and-hold” for individual stocks?

95

Can We STOP AF With Cryoballoon Ablation?

96

Can we stop national immunisation days before global eradication of poliomyelitis?

97

Can we study intelligence using the experimental method

98

Can we study quark matter in the quenched approximation? Original Research Article

99

Can we synthesise a dense bundle of quasi one-dimensional metallic wires?

100

Can we synthesise a dense bundle of quasi one-dimensional metallic wires?

101

Can we talk? How the cognitive neuroscience of attention emerged from neurobiology and psychology, 1980–2005

102

Can We Talk?: Importance of Random-Digit-Dial Surveys for Injury Prevention Research Review Article

103

Can We Target Smoking Groups More Effectively? A Study of Male and Female Heavy Smokers

104

Can We Tell How a Community Was Constructed? A Comparison of Five Evenness Indices for Their Ability to Identify Theoretical Models of Community Construction

105

Can We Treat Cognitive Deficits in Patients with Epilepsy?

106

Can we treat coronary artery disease with antibiotics?

107

Can we trust elemental abundances derived in late-type giants with the classical 1D stellar atmosphere models

108

Can We Trust Information?

109

Can we trust module-respect heuristics?

110

Can we trust module-respect heuristics?

111

Can we trust odor databases? Example of t- and n-butyl acetate

112

Can we trust PRA?

113

Can we trust PRA?

114

Can we trust the web?

115

Can we understand structural and tectonic processes and their products without appeal to a complete mechanics?

116

Can we unlock the potential of IGF-1R inhibition in cancer therapy?

117

Can we use area per surfactant as a quantitative test model of specific ion effects?

118

Can we use biomass produced from phytoremediation?

119

Can we use complex-valued fractional Brownian motion to derive a fractal space-time theory in micro-physics

120

Can we use disease to control biological invasion?—A theoretical research

121

Can we use disease to control biological invasion?—A theoretical research

122

Can we use erythrocytes for the study of the activity of the ubiquitous Na+/H+ exchanger (NHE-1) in essential hypertension?

123

Can we use fixed ambient air monitors to estimate population long-term exposure to air pollutants? The case of spatial variability in the Genotox ER study

124

Can We Use Heart Rate Recovery Information Generated by Supine Ergometry Exercise?

125

Can We Use Home Sleep Testing for the Evaluation of Sleep Apnea in Obese Pregnant Women?

126

Can we use in vitro fertilization tests to predict semen fertility?

127

Can we use indoor fungi as bioindicators of indoor air quality? Historical perspectives and open questions Review Article

128

Can We Use Placental Growth Factor-Based Tests to Assess Women With Suspected Pre-eclampsia?

129

Can we use serum gamma-glutamyl transferase levels to predict early mortality in stroke?

130

Can wealthy traders claim monopolies in common English words under the UK trade marks act 1994? British Sugar plc v. Robertson & Sons

131

Can Web 2.0 Enhance Community Participation in an Institutional Repository? The Case of PocketKnowledge at Teachers College, Columbia University Original Research Article

132

Can Weblogs and Microblogs Change Traditional Scientific Writing?

133

Can weblogs cause the emergence of social intelligence?: causal model of intention to continue publishing weblog in Japan

134

Can weighing lysimeter ET represent surrounding field ET well enough to test flux station measurements of daily and sub-daily ET? ☆

135

Can Weight Gain Predict the Outcome of Childhood Leukemia?

136

Can wetlands maintained for human use also help conserve biodiversity? Landscape-scale patterns of bird use of wetlands in an agricultural landscape in north India

137

Can white blood cell count be used as a predictor of atrial fibrillation following cardiac surgery? A short literature review

138

Can Wideband Absorbance Be Used in the Detection of Ossicular Chain Defects?

139

Can willingness to pay capture the value of altruism? An exploration of Sen’s notion of commitment

140

Can women in less-developed countries use a simplified medical abortion regimen?

141

Can Women Travel to The Policy-Making Level in Bangladesh? Rural Women’s Political Representation, Participation and Empowerment in the Context of Microfinance

142

Can women without visible pubococcygeal muscle in MR images still increase urethral closure pressures?

143

Can womenʹs autonomy impede male involvement in pregnancy health in Katmandu, Nepal?

144

Can wood ants distinguish between good and bad food patches on the forest floor?

145

Can wood quality justify local preferences for firewood in an area of caatinga (dryland) vegetation?

146

Can wooden poles be used to reconnect habitat for a gliding mammal?

147

Can Working Memory Be Trained through Learning an Additional Language? the effects of TPR versus PPP

148

Can world real interest rates explain business cycles in a small open economy?

149

Can worriers be winners? The association between worrying and job performance

150

Can Wrist Blood Pressure Oscillometer Be Used for Triage in an Adult Emergency Department?

151

Can yeast systems biology contribute to the understanding of human disease? Original Research Article

152

Can Yesterday’s Demand-Side Management Lessons Become Tomorrow’s Market Solutions?

153

Can Yin-Chai-Xiao-Du decoction be useful of COVID-19? the mechanism research based on network pharmacology

154

Can Yoga Be Considered as an Effective Supportive Psychological Intervention with an Impact on the Quality of Life for Breast Cancer Survivors?

155

Can You Adhere Me Now? Good

156

Can You Answer a Question for Me? Processing Indirect Speech Acts

157

Can you bank on GenBank?

158

Can you believe my eyes? The importance of interobserver reliability statistics in observations of animal behaviour

159

Can You Buy a Business Relationship?: On The Importance of Customer and Supplier Relationships in Acquisitions

160

Can you dig it? Use of excavation, a risky foraging tactic, by dugongs is sensitive to predation danger

161

Can you guess the game you are playing?

162

Can you hear the dinner bell? Response of cyprinid fishes to environmental acoustic cues

163

Can you judge a book by its cover? Evidence of self–stranger agreement on personality at zero acquaintance

164

Can you judge a book by its cover? Evidence of self–stranger agreement on personality at zero acquaintance

165

Can you move one eye only?

166

Can you pay people to be healthy?

167

Can You Predict What Happens When EuroSCORE Weds Biomarker?

168

Can you recommend a good book on indexing? Collected reviews on the organization of information : by Bella Hass Weinberg, with a Foreword by Linda K. Fetters and an Index by Susan Klement. Medford, NJ: American Society of Indexers/Information Today, 1998.

169

Can you recommend a good book on indexing?: A Response to the review

170

Can you see the writing on my wall?

171

Can you teach old dogs new tricks? On complementarity of human capital and incentives

172

Can you tickle yourself if you swap bodies with someone else?

173

Can you Trust a Single Data Source Exploratory Software Engineering Case Study?

174

Can younger students succeed where older students fail? An examination of third gradersʹ solutions of a division-with-remainder (DWR) problem

175

Can your institution’s name influence constituent response? An initial assessment of consumer response to college names

176

Can YouTube enhance student nurse learning?

177

Can Zerhouni create a bold, risk-taking NIH?

178

Can Zeta sperm selection method, recover sperm with higher DNA integrity compare to density gradient centrifugation?

179

Can Zinc Be an Option for Prevention of Corona Virus Disease 2019?

180

Can β-blocker therapy be withdrawn from patients with dilated cardiomyopathy?, ,

181

Can γ-radiometrics predict soil textural data and stoniness in different parent materials? A comparison of two machine-learning methods

182

Can δ13C abundance, water-soluble carbon, and light fraction carbon be potential indicators of soil organic carbon dynamics in Zoigê wetland?

183

CAN/[nbp]FeCl4 as a Reusable Catalytic System for Direct Conversion of Trimethylsilyl Ethers to Their Acetates Under Microwave Irradiation

184

Can’t Catch a Breath

185

Can’t see the wood for the trees, can’t see the trees for the numbers? Accounting education, sustainability and the Public Interest

186

Can’t shake that feeling: event-related fMRI assessment of sustained amygdala activity in response to emotional information in depressed individuals

187

188

Canada – Titanium Corp Inc – TiO2 feedstock from tar sand tailings

189

Canada & US: Clariant – masterbatch

190

Canada advises against use of phthalates in childrenʹs toys

191

Canada apologises to native people who suffered abuse

192

CANADA AS A NEW PLACE: THE IMMIGRANT’S EXPERIENCE

193

Canada bans Pigment Red 3 for use as cosmetics ingredient

194

Canada delays legislation on cheap drugs

195

Canada draws near to approving Africa drugs deal

196

Canada finally launches national HIV/AIDS strategy

197

Canada gets fund for health services research

198

Canada gets tough with reproductive technologies

199

Canada hits back at tobacco companies

200

Canada increases breast screening and research

201

Canada introduces “evidence-based” guidelines for breast-cancer care

202

Canada launches breast-cancer strategy

203

Canada lifts ban on blood donors with Creutzfeldt-Jacob disease

204

Canada makes vaccine biotech investment

205

Canada may ban Disperse Blue 19, PDDAM & Pigment Red 251

206

Canada moves to protect babies from chemical

207

Canada moves to stem health-research “brain drain”

208

Canada moves towards “whistle-blowing” law

209

Canada needs better drug reporting, says inquest

210

Canada outlines 10-year research strategy that will “take on the world”

211

Canada plans mental-health outreach

212

Canada post delivers energy conservation

213

Canada proposes strict tobacco controls

214

Canada puts Health Act up for negotiation

215

Canada reacts to water contamination

216

Canada rules no fetal rights

217

Canada sends out urgent appeal for blood

218

Canada shootings linked with abortion

219

Canada silences scientists that spoke out about BSE

220

Canada starts renewed effort against tobacco-industry advertising

221

Canada still seeking research code of ethics

222

Canada strengthens pandemic plan in wake of SARS

223

Canada Thistle [Cirsium arvense (L) Scop.] Response to Density of Cassida rubiginosa Müller (Coleoptera: Chrysomelidae) and Plant Competition

224

Canada to abolish fee-for-service in primary care?

225

Canada to change patent law to allow export of cheap drugs

226

Canada to define essential medical care

227

Canada to limit artificial reproduction technologies

228

Canada to overhaul blood system

229

Canada unveils plans for new blood authority

230

Canada upholds rights of pregnant women

231

Canada waits for “grandaddy” of health-reform studies

232

Canada, South Korea, Netherlands and Sweden: regulatory implications of the convergence of telecommunications, broadcasting and Internet services

233

Canada: Atlantic – barytes

234

Canada: Black Bull – kaolin

235

Canada: Canadian Wollastonite – wollastonite

236

Canada: Cancarb – carbon black

237

Canada: Clariant — plastics masterbatch

238

Canada: Clariant — plastics masterbatch

239

Canada: Ferrinov – anti-corrosion pigments from furnace flue-dust

240

Canada: Hillsborough/NW Pozzolan – kaolin

241

Canada: Optima – plastics masterbatch

242

Canada: QIT – TiO2 feedstock

243

Canada: Rio Tinto – TiO2 feedstock

244

Canada: Western Oil Sands & Altair – TiO2 feedstock & pigment

245

Canada: Western Oil Sands & Altair – TiO2 feedstock & pigment

246

Canada: What it is, What it can be, R. Martin, J. Milway. Toronto University Press, Toronto, ON (2012)

247

Canada: Whitemud – kaolin for cement

248

Canada: Whitemud – kaolin for cement

249

Canada: Whitemud – kaolin for cement

250

Canada’s constitutional separation of (wind) power

251

Canada’s energy perspectives and policies for sustainable development

252

Canada’s New Mental Disorder Disposition Provisions:: A Case Study of the British Columbia Criminal Code Review Board

253

Canada’s Pioneering Women of Vascular Surgery: A Historical Review

254

Canada’s program on nuclear hydrogen production and the thermochemical Cu–Cl cycle

255

Canada’s voluntary agreement on vehicle greenhouse gas emissions: When the details matte

256

Canadaʹs antismoking initiative goes ahead

257

Canadaʹs antitobacco stance even tougher

258

Canadaʹs Atlantic Coastal Action Program: A community-based approach to collective governance

259

Canadaʹs blood inquiry gains strength

260

Canadaʹs British Columbia attacks tobacco companies

261

Canadaʹs budget causes mixed emotions

262

Canadaʹs cancer costs rise

263

Canadaʹs centres of excellence will stay

264

Canadaʹs doctors post reward for abortionistsʹ killers

265

Canadaʹs doctors want technology investment

266

Canadaʹs doctors win

267

Canadaʹs drug industry put under pressure

268

Canadaʹs drug prices poorly controlled

269

Canadaʹs drug-cost burden on patients increases

270

Canadaʹs health care boosted before elections

271

Canadaʹs health ministry gains new chief

272

Canadaʹs health-care reform side tracked

273

Canadaʹs hepatitis C compensation derailed

274

Canadaʹs Liberals make solemn election vows

275

Canadaʹs Medicare principles defended

276

Canadaʹs Mental Health System

277

Canadaʹs ministers agree health package

278

Canadaʹs MRC and drug industry try to make amends

279

Canadaʹs new minerals and metals policy: Advancing the concept of sustainable development in the minerals and metals industry

280

Canadaʹs new prime minister vows to cut surgery wait lists

281

Canadaʹs new regulatory framework. Convergence, competition and the Information Highway

282

Canadaʹs ocean and maritime security a strategic forecast: A strategic forecast

283

Canadaʹs offer to host the ITER project

284

Canadaʹs pharmacists can sell prescribing data

285

Canadaʹs provinces tackle government for more money for Medicare

286

Canadaʹs Red Cross demands HCV-screening funds

287

Canadaʹs Red Cross on the offensive over its future role

288

Canadaʹs Red Cross sells blood assets

289

Canadaʹs research network virtually ready

290

Canadaʹs style of continuing medical education

291

Canadaʹs Supreme Court limits doctorʹs liability

292

Canadaʹs supreme court rejects broadcasterʹs appeal on doctorsʹ libel verdict

293

Canadaʹs university presidents “ecstatic” over funding for research

294

Canadaʹs unpopular health legislation passed

295

Canada-United States Chicken Trade: A Re-Evaluation

296

Canada-Wide Survey of the Nutritional Composition of Six Retail Pork Cuts

297

Canadian Aboriginal communities and medical service patterns for the management of injured patients: a basis for surveillance

298

Canadian Aboriginal peopleʹs experiences with HIV/AIDS as portrayed in selected English language Aboriginal media (1996–2000)

299

Canadian Aboriginal peopleʹs health and the Kelowna deal

300

Canadian Act may mean greater access to personal medical records

301

Canadian advanced life support capacities and future directions Original Research Article

302

Canadian Agricultural Safety Net Programs and Pressures for Change

303

Canadian agri-environmental indicators related to land quality: integrating census and biophysical data to estimate soil cover, wind erosion and soil salinity

304

Canadian AIDS doctor convicted of physicianassisted suicide

305

Canadian Alzheimer collaboration agreed

306

Canadian aquatic science and environmental legislation under threat

307

Canadian Association of Gastroenterology Indicators of Safety Compromise following Colonoscopy in Clinical Practice

308

Canadian Association of Gastroenterology: Strategic Plan 2016–2020

309

Canadian blood-donation prohibition for UK visitors

310

Canadian Bridge Design Code Provisions for Fiber-Reinforced Structures

311

Canadian budget gives healthcare a boost

312

Canadian ceramic breeder technology: recent results

313

Canadian cigarette packs to list toxins and hazards

314

Canadian collaboration networks: A comparative analysis of the natural sciences, social sciences and the humanities

315

Canadian compulsory community treatment laws: Recent reforms

316

Canadian court reaffirms reproductive rights

317

Canadian court says yes to tobacco advertising

318

Canadian court tells government to relax marijuana law for patients

319

Canadian CT head rule study for patients with minor head injury: methodology for phase II (validation and economic analysis)

320

Canadian Dietary Fat Substitutions, 1955–93, and Coronary Heart Disease Costs

321

Canadian doctorsʹ leaders take charge of project to reduce medical error

322

Canadian doctorʹs murder charge dropped

323

Canadian doctorsʹ prescribing habits for sale

324

Canadian doctors produce charter of demands

325

Canadian doctors vote for two systems

326

Canadian drive to curb drug expenditure

327

Canadian east coast marine-protected areas: A review

328

Canadian epidemiologists examine elective surgery

329

Canadian evidence on long-run neutrality propositions

330

Canadian Exports of Livestock and Meat to the United States

331

Canadian federal government policy and Canadaʹs electronic information industry

332

Canadian Federal Government requirements and support tools for pollution prevention planning

333

Canadian fetal-rights case decided

334

Canadian finance plan plugs health gaps exposed by SARS

335

Canadian genomics project gets kick start

336

Canadian geomorphology 2000: Introduction

337

Canadian government abandon deal for victims of tainted blood

338

Canadian government addresses chemical pollution

339

Canadian government agencies develop e-mail management policies

340

Canadian government allows more patients to use marijuana

341

Canadian government makes guarantees on Medicare

342

Canadian government survives HCV vote

343

Canadian government urged to improve end-of-life care

344

Canadian government will revisit human-cloning legislation

345

Canadian greenhouse gas emissions: 1990–2000

346

Canadian group calls for more environmental health studies

347

Canadian Headache Society criteria for the diagnosis of acute migraine headache in the ED—do our patients meet these criteria?

348

Canadian Health and Food: The Links between Policy, Consumers, and Industry

349

Canadian health-care spending soars

350

Canadian hopes for low-cost drugs dashed

351

Canadian hospitals call for restrictions on single-use devices

352

Canadian House Dust Study: Population-based concentrations, loads and loading rates of arsenic, cadmium, chromium, copper, nickel, lead, and zinc inside urban homes Original Research Article

353

Canadian hydrogen safety program

354

Canadian hypertension society guidelines for ambulatory blood pressure monitoring

355

Canadian infection-control experts push for health reform

356

Canadian insights: The challenges of an integrated environmental assessment framework

357

Canadian institutes fund new initiatives in health research

358

Canadian Intellectual Property Office: backfile conversion project: 1992–1996

359

Canadian judge allows marijuana as therapy

360

Canadian kimberlites: Geological characteristics relevant to emplacement

361

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

362

Canadian Macromolecular Crystallography Facility (CMCF) 08ID-1 status update

363

Canadian Medical Association champions private medicine

364

Canadian Medical Associationʹ president guilty of misconduct

365

Canadian men need a healthier lifestyle

366

Canadian mercury inventories: the missing pieces

367

Canadian military malarial prophylaxis under scr utiny

368

Canadian Milling Practice : Edited by B. Damjanovic and J.R. Goode xi + 292 pages 22x 28.7 cm, hard cover, published by Canadian Institute of Mining, Metallurgy, and Petroleum, Montreal 2000. Price $80 ($65 for members, $45 for students) + postage ($10 Ca

369

Canadian MRC encourages private sector partnership

370

Canadian multicenter pilot trial of haploidentical donor transplantation

371

Canadian National Air Pollution Surveillance (NAPS) PM2.5 speciation program: Methodology and PM2.5 chemical composition for the years 2003–2008

372

Canadian National Breast Screening Study

373

Canadian national power quality survey: frequency and duration of voltage sags and surges at industrial sites

374

Canadian naturopathic practitioners: holistic and scientific world views

375

Canadian NOx/VOC Science Assessment: science and policy linkages

376

Canadian Occupational Performance Measure Supported by Talking Mats: An Evaluation of the Clinical Utility

377

Canadian officials criticised over soldiersʹ care

378

Canadian officials watch SARS-like mystery bug

379

Canadian Opinions on Refractive Surgery and Approaches to Presbyopia Correction

380

Canadian panel calls for review of drug-trial confidentiality agreements

381

Canadian Parliament finally agrees human reproduction research act

382

Canadian pastoral: promotional images of British colonization in Lower Canadaʹs Eastern Townships during the 1830s

383

Canadian patent profile: Some explorations in patent statistics Original Research Article

384

Canadian petrochemical plants blamed for gender imbalance

385

Canadian practitionersʹ perception of research work investigating the cost premiums, long-term costs and health and productivity benefits of green buildings

386

Canadian programme reverses high anaemia incidence

387

Canadian prohibition against immigrants with disabilities is challenged

388

Canadian province opens door to two-tier health service

389

Canadian provincial health ministers press for change

390

Canadian R&D abroad management practices

391

Canadian Red Cross fires secretary-general

392

Canadian Red Cross found negligent

393

Canadian regulation of private security in an international perspective

394

Canadian regulatory approach to ensuring the implementation of effective ageing management programs for nuclear power plants

395

Canadian report quantifies cost of medical errors

396

Canadian researchers awarded record damages

397

Canadian researchers respond to CMAJ crisis

398

Canadian respirologistʹs murder trial appeal quashed

399

Canadian retailing strategy: Challenges and change : William A. Crowe and Mark E. Siemonsen Nelson Canada, Scarborough, Ontario: (1996) 444 pp. ISBN 0 17 6055770

400

Canadian scientists urge government to develop antibiotic plan

401

Canadian scientists vindicated over whistleblowing

402

Canadian settlement guarantees world medical isotope supply

403

Canadian soldiers and doctors face torture allegations

404

Canadian space environment program and international living with a star Original Research Article

405

Canadian spending on prescription drugs is increasing

406

Canadian Steinernematid (Nematoda) Isolates and Their Infectivity, under Cold Conditions, to Greater Wax Moth (Galleria mellonella) Larvae

407

Canadian suppliers of mining goods and services: links between Canadian mining companies and selected sectors of the Canadian economy: Minerals and Metals Sector; Natural Resources Canada, 2000, xvi + 58pp., free upon request, ISBN 0-662-84954-7, softcove

408

Canadian tourist information and the UK: plans and perceptions

409

Canadian universities go shopping for research scientists

410

Canadian university publishes new rules to protect scientists

411

Canadian waters provide critical foraging habitat for leatherback sea turtles Original Research Article

412

Canadians allow targeted transfusion

413

Canadians are fighting fit, says government report

414

Canadians finally fill regulatory void with stem-cell bill

415

Canadians in Alabama: a perceptual study of dialect acquisition in adults

416

Canadians inquire into drug licensing

417

Canadians propose overhaul of research-ethics guidelines

418

Canadians still stung by WHOʹs SARS travel advisory

419

Canagliflozin-associated Peripheral Vascular Ischemia: A Case Report

420

Canal blocking strategies for hydrological restoration of degraded tropical peatlands in Central Kalimantan, Indonesia

421

Canal configuration of mandibular first premolars in an Egyptian population

422

Canal Configuration of Mesiobuccal Roots in Permanent Maxillary First Molars in Iranian Population: A Systematic Review

423

Canal of Nuck hernias

424

Canal preparation for prosthetic radial head replacement: rasping versus reaming

425

Canal surfaces in 4-dimensional Euclidean space

426

Canal Transportation and Centering Ability of ProTaper and SafeSider in Preparation of Curved Root Canals: A CBCT Evaluation

427

Canal Transportation and Centering Ability of Reciproc Blue, WaveOne Gold and ProTaper Next in Simulated Curved Canals

428

Canal Transportation and Centering Ability of Twisted File and Reciproc: A Cone-Beam Computed Tomography Assessment

429

Canal Transportation and Centering after Using PathFile and R-Pilot in Mesiobuccal Canals of Maxillary Molars Using Cone-Beam Computed Tomography

430

Canal Transportation and Centring Ability of Reciproc and Reciproc Blue With or Without Use of Glide Path Instruments: A CBCT Study

431

Canal water treatment with rapid sand filtration

432

Canaletto’s paintings open a new window on the relative sea-level rise in Venice

433

Canalicular adenoma of the hard palate: A rare case report

434

Canalicular and Naolacrimal Duct Blockage: An Ocular ide Effect Aociated With the Antineoplatic Drug -1

435

Canalicular bile formation: beyond single transporter functions

436

Canalicular fluid flow induced by bending of a long bone

437

Canalis Sinuosus Damage after Immediate Dental Implant Placement in the Esthetic Zone

438

Canalization as a non-genetic source of adaptiveness during morphogenesis: experimental evidence from analysis of reproductive development in Sorghum bicolor

439

Canalization of development and ecdysteroid timing during the last instar in lubber grasshoppers

440

Canals and Communities. Small-scale Irrigation Systems, Edited by J. Mabry, University of Arizona Press, 1996. ISBN 0816515921, pp. 273

441

Canard phenomenon for an SIS epidemic model with nonlinear incidence

442

Canard solution and its asymptotic approximation in a second-order nonlinear singularly perturbed boundary value problem with a turning point

443

Canard solutions of two-dimensional singularly perturbed systems

444

Canards and mixed-mode oscillations in a forest pest model

445

446

CANARD-WING INTERACTIONS IN SUBSONIC FLOW

447

Canary current upwelling: More or less?

448

Canary in the coalmine: Norwegian attitudes towards climate change and extreme long-haul air travel to Aotearoa/New Zealand

449

Canary islands aborigin sex determination based on mandible parameters contrasted by amelogenin analysis

450

Canataxpropellane, a novel taxane with a unique polycyclic carbon skeleton (tricyclotaxane) from the needles of Taxus canadensis

451

Canavalia ensiformis urease, Jaburetox and derived peptides form ion channels in planar lipid bilayers

452

Canavan disease: a monogenic trait with complex genomic interaction

453

Canavanine content in sword beans (Canavalia gladiata): Analysis and effect of processing

454

CaNb2O6 ceramics prepared by a reaction-sintering process

455

c-ANCA as a marker of Wegenerʹs disease

456

c-ANCA as a serological pitfall

457

C-ANCA Positive Vasculitis in a Case of Amyloidosis

458

Cancarb appoints European agents for its Thermax thermal blacks

459

CAN-catalyzed syntheses of 3,4-dihydroquinoxalin-2-amine derivatives based on isocyanides

460

CAN-catalyzed three-component reaction between anilines and alkyl vinyl ethers: stereoselective synthesis of 2-methyl-1,2,3,4-tetrahydroquinolines and studies on their aromatization

461

462

Canceling out both the real and the spectral lines

463

Canceling print serials in favor of electronic: criteria for decision making

464

Cancellable biometerics featuring with tokenised random number

465

Cancellable biometrics and annotations on BioHash

466

Cancellation among finite unary algebras Original Research Article

467

Cancellation and Focus: The Role of Shared and Unique Features in the Choice Process

468

Cancellation Conditions for Finite Two-Dimensional Additive Measurement

469

Cancellation errors in an integral for calculating magnetic field from reduced scalar potential

470

Cancellation in cyclic consecutive systems

471

Cancellation is exponentially powerful for computing the determinant

472

Cancellation of bending-induced birefringence in single-mode fibers: application to Faraday sensors

473

Cancellation of Capacitor Parasitic Parameters for Noise Reduction Application

474

Cancellation of digraphs over the direct product

475

Cancellation of elective oral and maxillofacial operations

476

Cancellation of Elective Surgeries in a Tertiary Care Hospital in North India

477

Cancellation of fine-structure splitting in quantum dots by a magnetic field

478

Cancellation of Harmonic Interference by Baseline Shifting of Wavelet Packet Decomposition Coefficients

479

Cancellation of heat effects in catalytic distillation

480

Cancellation of image crosstalk in time-sequential displays of stereoscopic video

481

Cancellation of Infrared Divergences at Finite Temperature

482

cancellation of land certificate based on the court decision in indonesian legal system

483

CANCELLATION OF MASS-LOADING EFFECTS OF TRANSDUCERS AND EVALUATION OF UNMEASURED FREQUENCY RESPONSE FUNCTIONS

484

Cancellation of operations in Saudi Arabian hospitals: Frequency, reasons and suggestions for improvements

485

Cancellation of polarized impulsive noise using an azimuth-dependent conditional mean estimator

486

Cancellation of projective modules over regular rings with comparability Original Research Article

487

Cancellation of renormalon ambiguities in the heavy quark effective theory Original Research Article

488

Cancellation of second-order intermodulation distortion and enhancement of IIP2 in common-source and common-emitter RF transconductors

489

Cancellation of Series-Loss Resistance in UWB Active Inductors using RC Feedback

490

Cancellation of Simulated Environmental Noise as a Tool for Measuring Vocal Performance During Noise Exposure

491

Cancellation of star light generated by a nearby star–planet system upon detection with a rotationally-shearing interferometer

492

Cancellation of Sudakov logarithms in radiative decays of quarkonia Original Research Article

493

Cancellation of the Heating Piston Effect by Convective Enhancement of a Cooling Piston Effect

494

Cancellation problem of preconditioning method at low Mach numbers

495

Cancellation properties for quotient divisible groups

496

Cancellation properties of products of graphs

497

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

498

Cancellation Properties of Projective Modules over Laurent Polynomial Rings Original Research Article

499

Cancellation provisions in Australiaʹs Commonwealth-managed fisheries

500

Cancellation task in very low educated people

501

Cancellation techniques in underwater scattering of acoustic signals

502

Cancellation Theorems Related to Conjectures of Alperin and Dade

503

Cancellations in ambulatory day surgery: Ten years observational study

504

Cancellations in day-case ENT surgery

505

Cancellations in neutrinoless double beta decay and the neutrino mass matrix Original Research Article

506

Cancellative pairs of families of sets

507

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part I)

508

CancellativeAbelianMonoids and Related Structures in Refutational Theorem Proving (Part II)

509

Cancellativity properties for t-norms and t-subnorms

510

Cancelled IGF-1 trials bode ill for diabetic patients

511

Cancelling Jüttner distributions for space-like freeze-out

512

Cancelling quadratic divergences without supersymmetry Original Research Article

513

Cancelling vibrations in flexible articulated structures using non-causal inverse dynamics

514

Cancellous and cortical bone mineral density around an elastic press-fi t socket in total hip arthroplasty

515

Cancellous and cortical morselized allograft in revision total hip replacement:: A biomechanical study of implant stability

516

Cancellous bone architecture: Advantages of nonorthogonal trabecular alignment under multidirectional joint loading

517

Cancellous bone biomechanics

518

Cancellous bone lamellae strongly affect microcrack propagation and apparent mechanical properties: Separation of patients with osteoporotic fracture from normal controls using a 2D nonlinear finite element method (biomechanical stereology)

519

Cancellous bone mechanical properties from normals and patients with hip fractures differ on the structure level, not on the bone hard tissue level

520

Cancellous bone microdamage in the proximal femur: influence of age and osteoarthritis on damage morphology and regional distribution

521

Cancellous bone repair using bovine trabecular bone matrix particulates

522

Cancellous impaction and cortical strut allografting for revision shoulder arthroplasty: A case report

523

524

Cancer – Blame it all on viruses! Bladder tumours in cattle and sarcoids in horses may help us understand the relationship between some cancers and viruses

525

Cancer Risk in Pakistan Due to Natural Environmental Pollutants

526

Cancer “challenge” to limited-resource countries

527

Cancer ameliorating potential of Phyllanthus amarus: In vivo and in vitro studies against Aflatoxin B1 toxicity

528

Cancer among Farmers: A Meta-Analysis

529

Cancer and a Fatiguing Illness in Northern Nevada—A Causal Hypothesis

530

Cancer and aging: The molecular pathways

531

Cancer and Body Composition: An Association of Global Relevance

532

Cancer and comorbidity in older patients: A descriptive profile

533

Cancer and Complications of Peptic Ulcer in Type 2 Diabetes Mellitus patients at Wasit province, Iraq

534

cancer and covid-19: the synergistic burden on mental health status of patients with cancer

535

Cancer and Emotion; the Scope of Psycho‐Socio‐Oncology

536

Cancer and Emotion; The Scope of Psycho‐Socio‐Oncology: At the Time of Diagnosis

537

Cancer and Emotion; The Scope of Psycho-Socio-Oncology: At the Time of Treatment

538

Cancer and globalization

539

Cancer and HIV infection in Rwanda

540

Cancer and incontinence

541

Cancer and inflammation: A complex relationship

542

Cancer and its Treatment in Main Ancient Books of Islamic Iranian Traditional Medicine (7th to 14th Century AD)

543

Cancer and Low Levels of Plasma Cholesterol: The Relevance of Cholesterol Precursors and Products to Incidence of Cancer

544

Cancer and male infertility

545

Cancer and mutant DNA in blood plasma

546

Cancer and natural medicine: Textbook of basic science and clinical research: By John Boik, Oregon Medical Press, 1996

547

Cancer and Non-Cancer Risk of Arsenic in Drinking Water: A Case Study

548

Cancer and nonextensive statistics

549

Cancer and ovarian tissue cryopreservation

550

Cancer and psychosocial distress: frequent companions

551

Cancer and self-help: Bridging the troubled Waters of childhood illness : By Mark A. Chesler and Barbara K. Chesney. The University of Wisconsin Press, Madison, WI, 1995. 416 pp

552

Cancer and the human genome: no quick fix

553

Cancer and the meaning of work

554

Cancer and thromboembolic disease: how important is the risk of thrombosis?

555

Cancer and thromboembolic disease: pathogenic mechanisms

556

Cancer and thrombosis revisited

557

Cancer and venous thromboembolism

558

Cancer and Women’s Health

559

Cancer and wood-related occupational exposure in the Amazon region of Brazil

560

Cancer anorexia and cachexia

561

Cancer anorexia: a model for the understanding and treatment of secondary anorexia

562

Cancer anorexia: new pathogenic andtherapeutic insights

563

Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer

564

Cancer Antigens (CEA and CA 19-9) as Markers of Advanced Stage of Colorectal Carcinoma

565

Cancer as a Complex Genetic Trait: Tumor Susceptibility in Humans and Mouse Models

566

Cancer as an Embryological Phenomenon and Its Developmental Pathways: A Hypothesis regarding the Contribution of the Noncanonical Wnt Pathway

567

Cancer associated with obstetric delivery: results of linkage with the California cancer registry

568

Cancer biology and necrotic changes in metastatic lymph nodes and survival of colon cancer patients

569

Cancer biology for the clinic and the lab

570

Cancer biomarker and neurotransmitters recognition by molecularly imprinted xero-gels

571

Cancer biomarkers

572

Cancer Biomarkers

573

Cancer biomarkers detection using 3D microstructured protein chip: Implementation of customized multiplex immunoassay

574

Cancer Biomarkers: Closer to Delivering on their Promise

575

Cancer Biopsy in Ancient Persian Medicine: Do or Not to Do!

576

Cancer bio-repository

577

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

578

Cancer bronchique localement évolué : qu’apporte la radiothérapie avec modulation d’intensité rotationnelle ?

579

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

580

Cancer bronchique non à petites cellules de l’apex pulmonaire et chimioradiothérapie de haute dose : expérience du centre hospitalier Lyon-Sud

581

Cancer bronchique non à petites cellules localement évolué : place de la chimioradiothérapie exclusive

582

Cancer bronchique non à petites cellules: mise au point en 1998

583

Cancer bronchique : le drainage lymphatique

584

Cancer burden and trends in the asian pacific RIM region

585

Cancer cachexia

586

Cancer cachexia and its treatment with fish-oil-enriched nutritional supplementation

587

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

588

Cancer Cachexia, Malnutrition, and Tissue Protein Turnover in Experimental Animals

589

Cancer cachexia: Measured and predicted resting energy expenditures for nutritional needs evaluation

590

Cancer cachexia: Metabolic alterations and clinical manifestations

591

Cancer Cancer vaccines: a road map for the next decade

592

Cancer care during the natural disasters, the lessons learned from Kermanshah Earthquake in 2017

593

Cancer Care Ontario guaiac fecal occult blood test (FOBT) laboratory standards: Evidentiary base and recommendations

594

Cancer cell detection in tissue sections using AFM

595

Cancer cell dissemination during curative surgery for colorectal liver metastases

596

Cancer Cell Dynamics in Presence of Telomerase Inhibitors: Analysis of In Vitro Data

597

Cancer Cell Invasion: Treatment and Monitoring Opportunities in Nanomedicine

598

Cancer Cell Metabolism: Warburg and Beyond

599

Cancer Cell progression

600

Cancer Cell Separation Using Passive Mechanisms: a Review

601

Cancer cell separator using size-dependent filtration in microfluidic chip

602

Cancer Cells Display Profound Intra- and Interline Variation following Prolonged Exposure to Antimitotic Drugs

603

Cancer cells isolated from malignant pleural and peritoneal effusions inhibit phospholipase A2 activity in human polymorphonuclear leukocytes

604

Cancer Cells Release a Covalent Complex Containing Disulfide-Linked Domains from Urinary Plasminogen Activator, Neural Cell Adhesion Molecule, and Haptoglobin α and β Chains

605

Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate

606

Cancer chemoprevention by dietary chlorophylls: A 12,000-animal dose–dose matrix biomarker and tumor study

607

Cancer chemoprevention with garlic and its constituents

608

Cancer Chemoprevention. Vol. 2: Strategies for Cancer Chemoprevention.G.J. Kellof, E.T. Hawk and C.C. Sigman, Editors, Humana Press, Totowa (2005).

609

Cancer Chemoprevention. Volume I. Promising Cancer Chemopreventive Agents.G.J. Kelloff, E. T. Hawk and C.C. Sigman, Editors, P. Humana Press, Totowa (2004)

610

Cancer chemoprevention: A radical perspective

611

Cancer chemopreventive activity of 3,5,6,7,8,3′,4′-heptamethoxyflavone from the peel of citrus plants

612

Cancer chemopreventive activity of 3β-methoxyserrat-14-en-21β-ol and several serratane analogs on two-stage mouse skin carcinogenesis

613

Cancer chemopreventive activity of Achyranthes aspera leaves on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

614

Cancer chemopreventive activity of acridone alkaloids on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

615

Cancer chemopreventive activity of an iridoid glycoside, 8-acetylharpagide, from Ajuga decumbens

616

Cancer chemopreventive activity of carotenoids in the fruits of red paprika Capsicum annuum L.

617

Cancer chemopreventive activity of euglobal-G1 from leaves of Eucalyptus grandis

618

Cancer chemopreventive activity of flavanones on Epstein–Barr virus activation and two-stage mouse skin carcinogenesis

619

Cancer chemopreventive activity of majonoside-R2 from Vietnamese ginseng, Panax vietnamensis

620

Cancer chemopreventive activity of naphthoquinones and their analogs from Avicennia plants

621

Cancer chemopreventive activity of phenylpropanoid esters of sucrose, vanicoside B and lapathoside A, from Polygonum lapathifolium

622

Cancer chemopreventive activity of phenylpropanoids and phytoquinoids from Illicium plants

623

Cancer chemopreventive activity of serratane-type triterpenoids on two-stage mouse skin carcinogenesis

624

Cancer chemopreventive activity of synthetic colorants used in foods, pharmaceuticals and cosmetic preparations

625

Cancer chemopreventive agents, 4-phenylcoumarins from Calophyllum inophyllum

626

Cancer chemopreventive agents, labdane diterpenoids from the stem bark of Thuja standishii (Gord.) Carr

627

Cancer chemopreventive agents, serratane-type triterpenoids from Picea jezoensis

628

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

629

Cancer chemopreventive effect of dietary Zataria multiflora essential oils

630

Cancer chemopreventive effect of orally administrated lupane-type triterpenoid on ultraviolet light B induced photocarcinogenesis of hairless mouse

631

Cancer chemopreventive effect of quassinoid derivatives. Introduction of side chain to shinjulactone C for enhancement of inhibitory effect on Epstein–Barr virus activation

632

Cancer chemopreventive effects of constituents of Caesalpinia ferrea and related compounds

633

Cancer chemopreventive effects of oral feeding α-tocopherol on ultraviolet light B induced photocarcinogenesis of hairless mouse

634

Cancer chemopreventive effects of Pinus Maritima bark extract on ultraviolet radiation and ultraviolet radiation-7,12,dimethylbenz(a)anthracene induced skin carcinogenesis of hairless mice

635

Cancer chemopreventive effects of polyunsaturated fatty acids

636

Cancer Chemo-Preventive Effects of Red Propolis: a System Biology Approach

637

Cancer chemopreventive oltipraz generates superoxide anion radical

638

Cancer Chemoprotection by Oltipraz: Experimental and Clinical Considerations

639

Cancer chemotherapy – ribonucleases to the rescue Review Article

640

Cancer Chemotherapy and Biotherapy

641

Cancer chemotherapy in the older cancer patient

642

Cancer chemotherapy optimization under evolving drug resistance Original Research Article

643

Cancer chemotherapy with indole-3-carbinol, bis(3′-indolyl)methane and synthetic analogs

644

Cancer chemotherapy, biodiversity, public and private property: the case of the anti-cancer drug Taxol

645

Cancer chemotherapy: A SN-38 (7-Ethyl-10-hydroxycamptothecin) glucuronide prodrug for treatment by a PMT (Prodrug monoTherapy) strategy

646

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

647

Cancer chez le sujet âgé : place du dépistage gériatrique dans la décision thérapeutique

648

Cancer Classification in Microarray Data using a Hybrid Selective Independent Component Analysis and υ‑Support Vector Machine Algorithm

649

Cancer Classification with a Cost-Sensitive Naive Bayes Stacking Ensemble

650

Cancer Control at the Workplace: The Working Well Trial

651

Cancer Control strategy in the world, a review article

652

Cancer control: a reminder of the need for a balanced approach between prevention and treatment

653

Cancer cutané et xéroderma pigmentosum

654

Cancer cutané et xéroderma pigmentosum

655

Cancer de l’endomètre de stade I

656

Cancer de l’estomac : doses et volumes-cibles

657

Cancer de l’estomac. Le point thérapeutique en 2008

658

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

659

Cancer de la langue : expérience de l’Institut national d’oncologie de Rabat, à propos de 60 cas

660

Cancer de la prostate

661

Cancer de la prostate 2010. Innovations thérapeutiques

662

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

663

Cancer de la prostate chez l’homme de moins de 50 ans : à propos de 26 cas

664

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

665

Cancer de la prostate localisé et radiothérapie conformationnelle avec modulation d’intensité : quels sont les paramètres dosimétriques les plus pertinents pour prédire la toxicité digestive aiguë ?

666

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

667

Cancer de la prostate localisé, à risque intermédiaire ou élevé, dont le traitement a été une radiothérapie externe et incluant une curiethérapie de haut débit de dose : expérience du pôle régional de cancérologie de Poitou-Charentes

668

Cancer de la thyroïde après exposition aux rayonnements ionisants

669

Cancer de lʹœsophage : répercussion des thérapeutiques néoadjuvantes sur la morbidité et la mortalité opératoire

670

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

671

Cancer de prostate et RCMI guidée par l’image : absence de corrélation entre paramètres dose/volume des organes à risque et toxicité tardive

672

Cancer de prostate localisé. Que dire au patient ?

673

Cancer de prostate : doses et volumes cibles

674

Cancer death epidemics in United States Black males: Evaluating courses, causation, and cures

675

CANCER DEATH RATES AND BACKGROUND RADIATION

676

Cancer detection and mammogram volume of radiologists in a population-based screening programme

677

Cancer detection from textual data using a combination of machine learning approach

678

Cancer Detection Using Aritifical Neural Network and Support Vector Machine: A Comparative Study

679

Cancer Development and Electromagnetic Fields in Near Future

680

Cancer diagnosis by autofluorescence of blood components

681

Cancer Diagnosis Disclosure: What is the Right Thing to Do?

682

Cancer Diagnosis in Endoscopic Images using Discrete Wavelet Transform

683

Cancer diagnosis, treatment, and survival in Indigenous and non-Indigenous Australians: a matched cohort study

684

Cancer Disclosure in Iran: Attitude of Patients and Their Families

685

Cancer disclosure in Japan: Historical comparisons, current practices

686

Cancer distress screening: Needs, models, and methods

687

Cancer dose–response assessment for acrylonitrile based upon rodent brain tumor incidence: Use of epidemiologic, mechanistic, and pharmacokinetic support for nonlinearity

688

Cancer driver mutations in protein kinase genes

689

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

690

Cancer du canal anal : expérience de l’Institut national d’oncologie de Rabat, à propos de 110 cas

691

Cancer du cavum au centre tunisien : à propos de 525 cas

692

Cancer du cavum au centre tunisien : à propos de 525 cas

693

Cancer du cavum chez le sujet jeune

694

Cancer du cavum chez le sujet jeune

695

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

696

Cancer du cavum chez les sujets âgés : expérience d’un centre tunisien

697

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

698

Cancer du cavum dans l’ouest algérien : à propos de 578 cas traités à Oran, Algérie

699

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

700

Cancer du cavum dans la région de Marrakech. Expérience du service d’oncologie du centre hospitalier universitaire Mohammed-VI de Marrakech

701

Cancer du cavum dans le centre tunisien : facteurs pronostiques

702

Cancer du cavum dans le centre tunisien : facteurs pronostiques

703

Cancer du cavum du sujet âgé

704

Cancer du cavum du sujet âgé

705

Cancer du cavum et syndromes paranéoplasiques

706

Cancer du cavum et syndromes paranéoplasiques

707

Cancer du col utérin

708

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

709

Cancer du col utérin chez la femme jeune : à propos de 96 cas au Centre d’oncologie du CHU Ibn Rochd de Casablanca

710

Cancer du col utérin stades IB et II opérable : comparaison rétrospective entre curiethérapie utérovaginale préopératoire et chirurgie première suivies d’une radiothérapie

711

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

712

Cancer du col utérin : expérience du Maroc, à propos de 696 cas

713

Cancer du larynx chez le sujet âgé

714

Cancer du larynx chez le sujet âgé

715

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

716

Cancer du larynx : expérience de l’institut national d’oncologie de Rabat, à propos de 404 cas

717

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

718

Cancer du nasopharynx chez l’enfant et l’adolescent : expérience du service de radiothérapie et d’oncologie Ibn-Rochd de Casablanca

719

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

720

Cancer du nasopharynx dans l’Ouest algérien : résultats à long terme et facteurs pronostiques dans une cohorte de 200 cas

721

Cancer du pancréas localement évolué non resécable : chimioradiothérapie d’induction suivie de chimiothérapie par gemcitabine contre chimiothérapie exclusive par gemcitabine : résultats définitifs de l’étude de phase III 2000–2001de la FFCD et de la SFRO

722

Cancer du rectum avec métastases synchrone

723

Cancer du rectum avec métastases synchrone

724

Cancer du rectum chez le sujet de moins de 40 ans

725

Cancer du rectum chez le sujet de moins de 40 ans

726

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

727

Cancer du rectum localement évolué : place du boost tumoral en chimioradiothérapie concomitante préopératoire, étude rétrospective portant sur 75 cas

728

Cancer du rectum : volumes cibles de la radiothérapie préopératoire

729

730

Cancer du sein bilatéral après maladie de Hodgkin. Particularités clinico-histologiques et possibilités thérapeutiques: analyse de 13 cas

731

Cancer du sein chez la femme âgée

732

Cancer du sein chez la femme âgée

733

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

734

Cancer du sein chez la femme âgée de plus de 70 ans : expérience de l’Institut national d’oncologie de Rabat

735

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

736

Cancer du sein chez la femme de moins de 40 ans dans la région de Marrakech

737

Cancer du sein chez la femme jeune au Maroc

738

Cancer du sein chez la personne âgée : place de la radiothérapie ?

739

Cancer du sein chez la personne âgée : place de la radiothérapie ?

740

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

741

Cancer du sein d’emblée métastatique : impact de l’irradiation locorégionale exclusive sur la survie globale

742

Cancer du sein de la femme de moins de 35 ans

743

Cancer du sein de la femme de moins de 35 ans

744

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

745

Cancer du sein et radiothérapie peropératoire par électrons : revue des 100 premières patientes traitées à l’institut Jules-Bordet

746

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

747

Cancer du sein et ultrasons : de l’imagerie au traitement des cancers

748

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

749

Cancer du sein inflammatoire au centre hospitalier universitaire Hassan-II de Fès : à propos de 41 cas

750

Cancer du sein localement évolué non inflammatoire traité par association de chimiothérapie et de radiothérapie à dose préopératoire : réactualisation des résultats d’une série de 120 patientes

751

Cancer du sein métastatiques : intérêt du CA 15-3

752

Cancer du sein métastatiques : intérêt du CA 15-3

753

Cancer du sein négligé et localement évolué : quelle réalité ? Réflexion à propos de deux cas sur l’optimisation de la prise en charge multidisciplinaire

754

Cancer du sein secondaire chez l’homme après traitement pour maladie de Hodgkin. À propos d’un cas et revue de la littérature

755

Cancer du sein traité exclusivement par l’association d’une irradiation externe et d’une curiethérapie exclusive : résultats à long terme

756

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

757

Cancer du sein : comparaison dosimétrique entre la technique des filtres en coin et celle « champ dans le champ »

758

Cancer du sein. Questions et réponses au quotidien, J Saglier, EC Antoine. Masson, New York (1996), 125

759

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

760

Cancer du canal anal : comparaison dosimétrique entre radiothérapie trimensionnelle classique et par modulation d’intensité

761

Cancer education among primary care physicians in an underserved community

762

Cancer epidemiology and trends in Sistan and Baluchestan province, Iran

763

Cancer Epidemiology in Lebanon

764

Cancer Epidemiology in Radiation Oncology: An Institutional Experience From North India During 2016-2022

765

Cancer Epidemiology: The International Journal of Cancer Epidemiology, Detection and Prevention

766

Cancer epigenetics as biomarkers of clinical significance

767

Cancer epigenetics is no Mickey Mouse

768

Cancer epigenetics is no Mickey Mouse

769

Cancer Epigenetics: From Mechanism to Therapy

770

CANCER ESOPHAGUS: AN AUDIT OF CURRENT MANAGEMENT FOR YEMENI PATIENTS

771

Cancer Events After Acute or Chronic Exposure to Sulfur Mustard: A Review of the Literature

772

Cancer experts square up for European funds

773

Cancer familiarity status in patients with early brest cancer: Our experience

774

Cancer fatalism among african-americans: A review of the literature

775

Cancer Feature Selection and Classification Using a Binary Quantum-Behaved Particle Swarm Optimization and Support Vector Machine

776

Cancer gene may move quickly into skin clinics

777

Cancer gene therapy targeting cellular apoptosis machinery

778

Cancer genes and molecular oncology in the clinic

779

Cancer gene-therapy: clinical trials

780

Cancer Genetics and Cytogenetics

781

Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

782

Cancer genetics and genomics of human FOX family genes

783

Cancer Genetics and the Cardiotoxicity of the Therapeutics

784

Cancer genome sequencing: Understanding malignancy as a disease of the genome, its conformation, and its evolution

785

Cancer Genomes Evolve by Pulverizing Single Chromosomes

786

Cancer genomics

787

Cancer Genomics: The Road Ahead

788

Cancer groups meet in Edinburgh

789

cancer has an independent association with death in hospitalized patients with covid-19: a single-center study in iran

790

Cancer hazard identification and qualitative risk assessment

791

Cancer heterogeneity and “The Struggle for Existence”: Diagnostic and analytical challenges

792

Cancer hopes and setbacks

793

Cancer immunomics: Using autoantibody signatures in the early detection of prostate cancer

794

Cancer immunoprevention: tracking down persistent tumor antigens

795

Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

796

Cancer immunotherapy – broader considerations

797

Cancer Immunotherapy Using Microfluidic Systems

798

Cancer immunotherapy, mathematical modeling and optimal control

799

Cancer immunotherapy: novel strategies and clinical experiences

800

Cancer immunotherapy: simply cell biology?

801

Cancer immunotherapyʹs renaissance

802

Cancer in home care: Unintended weight loss and ethical challenges. A cross-sectional study of older people at 11 sites in Europe

803

Cancer in Kenya: types and infection-attributable. Data from the adult population of two National referral hospitals (2008-2012)

804

Cancer in Korean War Navy Technicians: Mortality Survey after 40 Years

805

Cancer in Lebanon: An Epidemiological Review of the American University of Beirut Medical Center Tumor Registry (1983–1994)

806

Cancer in married couples: Higher or lower distress?

807

Cancer in Maysan: Mortality, Pattern, and Demographic Characteristics during the Last 4 Decades

808

Cancer in patients on dialysis for end-stage renal disease: an international collaborative study Original Research Article

809

Cancer in patients on renal replacement therapy in Lombardy, Italy

810

Cancer in people with depression or anxiety: record-linkage study

811

Cancer in pregnancy: Gaps, challenges and solutions

812

Cancer in siblings of children with cancer in the Nordic countries: a population-based cohort study

813

Cancer in the mass print media: Fear, uncertainty and the medical model

814

Cancer in the older person

815

Cancer in the Sudan: An overview of the current status of knowledge on tumor patterns and risk factors Original Research Article

816

Cancer incidence among Danish Seventh-day Adventists and Baptists

817

Cancer incidence among Mormons and non-Mormons in Utah (United States) 1995–1999

818

Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study

819

Cancer incidence among refinery and petrochemical employees in Louisiana, 1983–1999

820

Cancer Incidence among the Elderly Population in the Northwest of Iran: A Population Based Study

821

Cancer incidence and asbestos in drinking water, Town of Woodstock, New York, 1980–1998

822

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

823

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism

824

Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study

825

Cancer Incidence and Mortality in Ardabil: Report of an Ongoing Population-Based Cancer Registry in Iran, 2004-2006

826

Cancer incidence and mortality in people aged less than 75 years: Changes in Australia over the period 1987–2007

827

Cancer Incidence and Prevalence in Isfahan: Application of Mortality Data to Estimates and Projects for the Period 2001-2015

828

Cancer Incidence and Trend Analysis in Shahroud, Iran, 2000 – 2010

829

Cancer Incidence around an Oil Refinery as an Example of a Small Area Study Based on Map Coordinates

830

Cancer incidence estimation at a district level without a national registry: A validation study for 24 cancer sites using French health insurance and registry data

831

Cancer incidence in a petrochemical industry area in Sweden Original Research Article

832

Cancer incidence in children conceived with assisted reproduction technology

833

Cancer incidence in Dutch Balkan veterans

834

Cancer incidence in ethnic German migrants from the Former Soviet Union in comparison to the host population

835

Cancer Incidence in Golestan Province: Report of an Ongoing Population-based Cancer Registry in Iran between 2004 and 2008

836

Cancer incidence in Jordan, 1996–2005

837

Cancer Incidence in Montana: Rates for American Indians Exceed Those for Whites Original Research Article

838

Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study

839

Cancer incidence in postwar Lebanon: findings from the first national population-based registry, 1998

840

Cancer Incidence in South East of Iran: Results of a Population-Based Cancer Registry

841

Cancer Incidence in Tehran Metropolis: The First Report from the Tehran Population-Based Cancer Registry, 1998 – 2001

842

Cancer incidence in the USA could double by 2050, report predicts

843

Cancer incidence in women exposed to DES in utero

844

Cancer Incidence Rate in the Elderly Inhabitants of Tehran: Is there Really any Cluster?

845

Cancer incidence rate ratios of Turkish immigrants in Hamburg, Germany: A registry based study

846

Cancer Incidence Rates among Iranian immigrants in Sweden, a Population-Based Retrospective Cohort Study

847

Cancer Incidence, Mortality and Survival in Türkiye as of 2020

848

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

849

Cancer indifférencié du cavum type : états des lieux dans le service de radiothérapie du centre hospitalier universitaire d’Oran

850

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

851

Cancer indifférencié du cavum : aspects épidémiologiques, cliniques et thérapeutiques

852

Cancer Induced Infertility and the Role of L-Carnitine: A Review for Possible Future Clinical Applications

853

Cancer informatics by prototype networks in mass spectrometry

854

Cancer Information Service-Initiated Outcalls to Promote Screening Mammography among Low-Income and Minority Women: Design and Feasibility Testing, ,

855

Cancer initiation by fumonisin B1 in rat liver – role of cell proliferation

856

Cancer Invasion and the Microenvironment: Plasticity and Reciprocity

857

Cancer Is to Embryology as Mutation Is to Genetics: Hypothesis of the Cancer as Embryological Phenomenon

858

Cancer letters special issue hepatocellular carcinoma featuring the guest editors

859

Cancer Letters special issue inflammation and gastrointestinal and liver cancers featuring the guest editor

860

Cancer Letters. Featuring the guest editors: Wael M. ElShamy and Roy J. Duhé

861

Cancer magnitude, challenges and control in the Eastern Mediterranean Region

862

Cancer marker detection in human serum with a point-of-care low-cost system

863

Cancer metabolism and the dynamics of metastasis

864

Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy

865

Cancer Metabolism: Is Glutamine Sweeter than Glucose?

866

Cancer metastasis at a glance: A brief view of Breast Cancer Brain Metastasis

867

Cancer Metastasis Is Accelerated through Immunosuppression during Snail-Induced EMT of Cancer Cells

868

Cancer mode of action, weight of evidence, and proposed cancer reference value for hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)

869

Cancer Modeling and Simulation, L. Preziosi (Ed.). Chapman and Hall/CRC (2003)

870

Cancer Modeling in the Modern Era: Progress and Challenges

871

Cancer Molecular Analysis Project: Weaving a rich cancer research tapestry

872

Cancer molecules reveal their mechanisms

873

Cancer morbidity in subjects occupationally exposed to high frequency (radiofrequency and microwave) electromagnetic radiation

874

Cancer mortality among agricultural workers from Serrana Region, state of Rio de Janeiro, Brazil

875

Cancer mortality among workers in formaldehyde industries

876

Cancer mortality among workers in the meat department of supermarkets : E. S. Johnson, Occupational and Environmental Medicine, 51(8), 541–547

877

Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland

878

Cancer mortality and offset printing

879

Cancer mortality and prevention in the European Union

880

Cancer mortality around French nuclear sites

881

Cancer mortality in Basrah: a household survey results

882

Cancer nanomedicine: A review on approaches and applications towards targeted drug delivery

883

Cancer nanomedicines targeting tumor extracellular pH

884

Cancer nanomedicines: So many papers and so few drugs!

885

Cancer nanotechnology

886

Cancer nanotechnology

887

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

888

Cancer Nursing: Care in Context: Jessica Corner, Christopher Bailey (Eds.); Blackwell Science, Oxford, 2001, ISBN 0-632-03998-1

889

Cancer Occurrence in Fars Province, Southern Iran

890

Cancer Occurrence in the Elderly: Agreement between Three Major Data Sources

891

Cancer of children in Basrah-Iraq: Person and time characteristics

892

Cancer of Male Urethra: Case Series and Review of Literature

893

Cancer of the breast, fifth edition.: William L. Donegan and John S. Spratt publisher: Saunders, Philadelphia, pages: 1,025. price: $179.00

894

Cancer of the breast: Is radiation therapy curative

895

Cancer of the Colon and Rectum in California: Trends in Incidence by Race/Ethnicity, Stage, and Subsite,

896

Cancer of the esophagus: histopathological sub-types in northern Uganda

897

Cancer of the gastric cardia

898

Cancer of the gastrointestinal tract results in a restricted T-cell repertoire dependent upon tumor differentiation

899

Cancer of the larynx in females

900

Cancer of the larynx in Hong Kong: a clinico-pathological study

901

Cancer of the pharynx and larynx

902

Cancer of the rectum—palliative endoscopic treatment

903

Cancer of unknown primary origin: a decade of experience in a community-based hospital

904

Cancer of unknown primary patients with midline nodal distribution: Midway between poor and favourable prognosis?

905

Cancer omics: From regulatory networks to clinical outcomes

906

Cancer onset and progression: A genome-wide, nonlinear dynamical systems perspective on onconetworks

907

Cancer pain relief achieved in mice with proenkephalin-expressing herpes vector

908

Cancer pain relief, 2nd Edn : WHO, Geneva. £11.90, ISBN 92 4 154482 1

909

Cancer Pain; Physical Factors affecting Pain Experience

910

Cancer paper retracted

911

Cancer patient advocacy: New opportunities for treatment advances

912

Cancer patient survival in Estonia 1995–2009: Time trends and data quality

913

Cancer patients and loneliness: A systematic review

914

Cancer patients desire for information: a study in a teaching hospita l in Saudi Arabia

915

Cancer patients overestimate survival chances

916

Cancer patients' satisfaction with communication and information given by nurses at teaching hospitals of Tehran, Iran

917

Cancer patientsʹ satisfaction with physicians: Princess Margaret hospital satisfaction with doctor questionnaire results

918

Cancer Patients Who Elect Euthanasia as an Option: An Argumentative Essay

919

Cancer Patients’ Challenges During COVID-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making i

920

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

921

Cancer Patients’ Perceptions of Family Psychological Support: A Qualitative Study

922

Cancer patients’ reluctance to discuss psychological distress with their physicians was not associated with underrecognition of depression by physicians: A preliminary study

923

Cancer pattern and survival in a rural district in South India

924

Cancer prevention

925

Cancer Prevention - Behavior Changes: The Short and the Long of It

926

Cancer prevention – the potential for diet to modulate molecular signalling

927

Cancer Prevention & Control Strategy: Resolution adopted by the 58th World Health Assembly, Geneva, May 25, 2005

928

Cancer Prevention Among Urban Southwestern American Indian Women: Comparison to Selected Year 2000 National Health Objectives

929

Cancer prevention by carotenoids

930

Cancer prevention by food factors through targeting signal transduction pathways,

931

Cancer Prevention by Protease Inhibitors

932

Cancer prevention by tocopherols and tea polyphenols

933

Cancer prevention in primary care: Predictors of patient counseling across four risk behaviors over 24 months

934

Cancer prevention in rural primary care: An academic-practice partnership

935

Cancer prevention studies: Past, present, and future directions

936

Cancer prevention studies—Past, present, and future directions

937

Cancer prevention trials and primary care physicians: Factors associated with recommending trial enrollment

938

Cancer Prevention: Chemoprevention vs Dietary Modifications

939

Cancer prevention: epidemiology and experiment

940

Cancer Prevention; Cancer Risk Management

941

Cancer Prevention; Emerging Infectious Diseases as Risk Factors, Iran Feature

942

Cancer preventive agents, Part 2: Synthesis and evaluation of 2-phenyl-4-quinolone and 9-oxo-9,10-dihydroacridine derivatives as novel antitumor promoters Original Research Article

943

Cancer preventive agents. Part 1: Chemopreventive potential of cimigenol, cimigenol-3,15-dione, and related compounds Original Research Article

944

Cancer preventive effects of flavonoids—a review

945

Cancer preventive potential of trichothecenes from Trichothecium roseum Original Research Article

946

Cancer preventive properties of ginger: A brief review

947

Cancer preventive screening: A cross-border comparison of United States and Canadian Chinese women

948

Cancer procoagulant and blood platelet activation

949

Cancer progression and p53

950

Cancer progression is associated with increased expression of basement membrane proteins in three-dimensional in vitro models of human oral cancer

951

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

952

Cancer prostatique localisé traité par irradiation conformationnelle avec modulation dʹintensité avec ou sans repositionnement échographique : la dose reçue est-elle équivalente à la dose prescrite ?

953

Cancer proteomics: from signaling networks to tumor markers

954

Cancer proteomics: from signaling networks to tumor markers

955

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

956

Cancer radio induit par la radiothérapie des carcinomes nasopharyngés : à propos de huit cas

957

Cancer rectocolique chez le sujet jeune

958

Cancer rectocolique chez le sujet jeune

959

Cancer Registry in Iran: a Brief Overview

960

Cancer related factors do not explain the quality of life scores for childhood cancer survivors analysed with two different generic HRQL instruments

961

Cancer Related Fears in Iranian Patients, a Survey from South East of Iran

962

Cancer related inflammation: The macrophage connection

963

Cancer research priorities for early diagnosis in Iran: Analyses based on Multiple-Attribute Decision Making Model

964

Cancer Research Studies in Native Hawaiians and Pacific Islanders

965

Cancer Research UK looks to NCI forsuccess

966

Cancer researchers get down to arrays at AACR

967

Cancer Resection on the Residual Lung After Pneumonectomy for Bronchogenic Carcinoma

968

Cancer responds better to combined treatments

969

Cancer risk above 1 Gy and the impact for space radiation protection Original Research Article

970

Cancer risk after a hospital discharge diagnosis of endometriosis, , ,

971

Cancer risk after non-melanoma skin cancer

972

Cancer risk among patients with multiple sclerosis: A cohort study in Isfahan, Iran

973

Cancer risk analysis by fuzzy logic approach and performance status of the model

974

Cancer Risk Analysis of Benzene and Ethyl Benzene in Painters

975

Cancer risk and all-cause mortality among Norwegian military United Nations peacekeepers deployed to Kosovo between 1999 and 2011

976

Cancer risk and Barrett’s esophagus

977

Cancer Risk Assessment and the Genetic Counseling Process: Using Hereditary Breast and Ovarian Cancer as an Example

978

Cancer Risk Assessment Benzene, Toluene, Ethylbenzene and Xylene (BTEX) in the Production of Insulation Bituminous

979

Cancer Risk Assessment due to Accidental Exposure inside Neutron Laboratories using BEIR VII Model

980

Cancer risk assessment for Tehran research reactor and radioisotope laboratory with CAP88-PC code (Gaussian plume model)

981

Cancer Risk Assessment for Workers Exposed to Pollution Source, a Petrochemical Company, Iran

982

Cancer Risk Assessment From Multi-Exposure to Chloroform in Drinking Water of Ilam City, Iran

983

Cancer risk assessment from trihalomethanes in drinking water

984

Cancer Risk Assessment in Welder's Under Different Exposure Scenarios

985

Cancer risk assessment using blood dioxin levels and daily dietary TEQ intake in general populations of industrial and non-industrial countries

986

Cancer Risk Assessment: Evolution of the Process

987

Cancer Risk Assessment: Quality and Impact of the Family History Interview

988

Cancer Risk at Sites Other than the Breast Following Augmentation Mammoplasty

989

Cancer risk due to contamination: Consideration from market basket survey in Qatar

990

Cancer risk factors among men of diverse Hispanic or Latino origins

991

Cancer risk in endoscopically unresectable colon polyps

992

Cancer risk in hypertensive patients treated with calcium channel blockers

993

Cancer risk in menopausal women

994

Cancer risk in patients on dialysis

995

Cancer risk in patients on dialysis and after renal transplantation Original Research Article

996

Cancer risk in patients with monoclonal gammopathy of undetermined significance

997

Cancer risk models and preselection for screening

998

Cancer risk, hypertension, and antihypertensive medication

999

Cancer risks associated with the diagnosis of infertility

1000

Cancer risks in children with congenital malformations in the nervous and circulatory system—A population based cohort study

بازگشت